NYSE$ATR

AptarGroup Inc. · Q1 2020 earnings

Q1 2020 earnings · · Investor relations

Briefing

AptarGroup's Q1 2020 results were reported.

AptarGroup's Q1 2020 results showed a decrease in reported sales by 3% to $722 million, with core sales, excluding currency and acquisition effects, decreasing by 2%. EPS was $0.84, a decrease of 13% compared to the prior year. The Pharma segment saw core sales growth of 7%, offsetting declines in other segments. The company is deemed an essential supplier and is monitoring the COVID-19 pandemic's impact.

  • Reported sales decreased 3% due to currency exchange rates, lower resin costs, and COVID-19 impacts.
  • Core sales, excluding currency and acquisition effects, decreased 2%.
  • Pharma segment core sales grew 7%, offsetting declines in other segments.
  • Adjusted earnings per share totaled $0.93, an 11% decrease year-over-year.

Headline financials

Total Revenue

$722M

Previous: $744M-3.1%
EPS (adj)

$0.93

Previous: $1.07-13.1%
Total Core Sales Growth

-2.0%

No prior period
Pharma Core Sales Growth

7.0%

No prior period
Beauty Core Sales Growth

-9.0%

No prior period
Closures Core Sales Growth

-2.0%

No prior period
Capital Expenditures

-$61.6M

Previous: -$51.7M-19.1%
Free Cash Flow

-$6.38M

Previous: $11.3M-156.6%
Net Income

$55.3M

Previous: $63M-12.3%
Operating Income

$88.5M

Previous: $97.1M-8.9%
Gross Profit

$722M

Previous: $744M-3.1%
Cash & Equivalents

$411M

Previous: $217M+89.0%
Total Assets

$3.78B

Previous: $3.42B+10.6%
Stock-Based Comp

$9.14M

Previous: $6.57M+39.2%

Revenue & EPS history

AptarGroup · Revenue · Quarterly

$722M

Q1 2020-3.1%vs Q1 2019
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

AptarGroup · $722M total across 3 segments · Q1 2020

  • Beauty
    $325M-11.7%
  • Pharma
    $297M+9.0%
  • Closures
    $99.8M

Forward guidance

Aptar expects the coming quarter to mark the worst of the expected COVID-19 impacts on our business and we anticipate a gradual recovery in the second half of the year.

Tailwinds

  • Broad portfolio of dispensing, drug delivery and active packaging solutions
  • Growing services platforms
  • New partnerships
  • Balance sheet remains in excellent condition
  • Continue to diligently manage costs and capacities

Headwinds

  • Duration and severity of the COVID-19 pandemic
  • Pace and scope of reopening in regions that are currently under government confinement orders
  • Speed at which beauty and other retail stores open
  • Willingness of consumers to participate in those shopping channels
  • Rate at which airline travel will resume and the general level of on-the-go consumption

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2020

Historical avgQ1 2020

+0.3%

Avg return

Earnings day

-0.1%

Avg return

5 days after

+1.2%

Avg return

30 days after

63%

43 / 68 earnings

Positive

+9.2%

Q4 2017

Best reaction

-9.0%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.3%-0.8%-6.4%
Q4 2025+8.3%+12.9%+6.5%
Q3 2025-9.0%-7.1%+0.3%
Q1 2025+2.3%+2.1%+6.8%
Q4 2024-8.5%-9.4%-2.3%
Q3 2024+0.8%+0.6%+2.3%
Q2 2024+1.7%+1.1%+4.4%
Q1 2024+2.4%+3.1%+5.8%
Q4 2023+5.4%+3.1%+8.6%
Q3 2023+0.1%-0.9%+4.2%
Q2 2023+3.2%+2.1%+6.3%
Q1 2023+2.4%+4.1%-1.4%
Q4 2022+5.7%+4.2%+0.3%
Q3 2022+2.1%-1.9%+6.9%
Q2 2022+1.6%+0.5%-1.5%
Q1 2022+3.4%+2.5%-2.0%
Q4 2021+3.3%+3.8%+2.7%
Q3 2021-3.6%+1.7%+1.0%
Q2 2021-6.3%-6.6%-2.3%
Q1 2021-0.2%+2.6%-2.5%
Q4 2020-7.7%-10.4%-2.7%
Q3 2020+1.6%+6.4%+13.3%
Q2 2020-3.0%-0.2%-0.6%
Q1 2020-3.6%-4.1%+1.2%
Q4 2019-2.6%-7.0%-19.6%
Q3 2019-7.1%-8.9%-6.0%
Q2 2019-5.0%-5.4%-1.3%
Q1 2019+1.3%+2.3%+2.0%
Q4 2018+1.5%+0.0%+2.2%
Q3 2018+1.8%+2.1%+2.0%
Q2 2018+8.6%+8.1%+9.6%
Q1 2018+0.3%+0.4%+1.0%
Q4 2017+9.2%+11.8%+9.6%
Q3 2017-0.6%-1.6%-2.5%
Q2 2017-6.5%-6.3%-6.4%
Q1 2017+1.2%+1.1%+6.3%
Q4 2016+1.7%+0.4%+4.4%
Q3 2016-4.3%-7.4%-0.3%
Q2 2016-1.9%-3.9%-1.6%
Q1 2016-3.1%
Q4 2015-2.8%
Q3 2015+2.4%
Q2 2015+8.3%
Q1 2015+2.4%
Q4 2014+1.8%
Q3 2014+2.0%
Q2 2014-3.5%
Q1 2014-0.1%
Q4 2013+1.9%
Q3 2013+0.2%
Q2 2013-2.1%
Q1 2013-2.0%
Q4 2012-0.8%
Q3 2012-3.5%
Q2 2012+2.6%
Q1 2012+0.9%
Q4 2011+0.1%
Q3 2011+5.8%
Q2 2011-5.0%
Q1 2010+2.2%
Q1 2011+2.3%
Q4 2008+1.5%
Q4 2010+1.5%
Q3 2010+2.9%
Q3 2009+2.9%
Q4 2009+0.5%
Q2 2009+0.5%
Q2 2010+0.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro